Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(153)
•••
Comment by newdaydawningon Sep 27, 2019 5:58pm
226 Views
Post# 30172480

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Please stop b!tching about RDW and Kristina

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Please stop b!tching about RDW and KristinaOne important detail you left out about the business development manager; he is also the company founder. Without him, this entire discussion would be moot. So yes, I support founders getting rich rewards for the risks they have taken with their own money since TLT's inception.


goldn1 wrote:
his attendance at those brokerage meetings, including maxim in New York City, came directly from him when he told me as he was looking to raise PP funds... If you actually believe the CEO's don't report to him and he is still the leader of this company, your just clueless. 4 million options for business development manager??? Smh, no actual CEO would approve that and then negotiate 50 cent warrants for themselves. Wake up NDD... G1


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities